annual total liabilities:
$358.77M+$11.19M(+3.22%)Summary
- As of today (September 16, 2025), XERS annual total liabilities is $358.77 million, with the most recent change of +$11.19 million (+3.22%) on December 31, 2024.
- During the last 3 years, XERS annual total liabilities has risen by +$149.27 million (+71.25%).
- XERS annual total liabilities is now at all-time high.
Performance
XERS Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$353.99M+$3.41M(+0.97%)Summary
- As of today (September 16, 2025), XERS quarterly total liabilities is $353.99 million, with the most recent change of +$3.41 million (+0.97%) on June 30, 2025.
- Over the past year, XERS quarterly total liabilities has increased by +$2.97 million (+0.85%).
- XERS quarterly total liabilities is now -1.33% below its all-time high of $358.77 million, reached on December 31, 2024.
Performance
XERS quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
XERS Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.2% | +0.8% |
| 3 y3 years | +71.3% | +44.7% |
| 5 y5 years | - | +150.3% |
XERS Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +71.3% | -1.3% | +44.7% |
| 5 y | 5-year | at high | +186.1% | -1.3% | +187.2% |
| alltime | all time | at high | >+9999.0% | -1.3% | +1132.8% |
XERS Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $353.99M(+1.0%) |
| Mar 2025 | - | $350.58M(-2.3%) |
| Dec 2024 | $358.77M(+3.2%) | $358.77M(+2.7%) |
| Sep 2024 | - | $349.43M(-0.5%) |
| Jun 2024 | - | $351.02M(+1.5%) |
| Mar 2024 | - | $345.79M(-0.5%) |
| Dec 2023 | $347.58M(+16.1%) | $347.58M(+7.3%) |
| Sep 2023 | - | $323.92M(+2.8%) |
| Jun 2023 | - | $315.14M(+8.2%) |
| Mar 2023 | - | $291.31M(-2.7%) |
| Dec 2022 | $299.45M(+42.9%) | $299.45M(+20.8%) |
| Sep 2022 | - | $247.98M(+1.4%) |
| Jun 2022 | - | $244.67M(+1.5%) |
| Mar 2022 | - | $241.17M(+15.1%) |
| Dec 2021 | $209.49M | $209.49M(+56.7%) |
| Sep 2021 | - | $133.72M(+1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $131.61M(+6.8%) |
| Mar 2021 | - | $123.25M(-1.7%) |
| Dec 2020 | $125.39M(+181.0%) | $125.39M(-19.6%) |
| Sep 2020 | - | $156.05M(+10.3%) |
| Jun 2020 | - | $141.43M(+58.2%) |
| Mar 2020 | - | $89.39M(-5.5%) |
| Dec 2019 | - | $94.55M(+12.0%) |
| Sep 2019 | - | $84.44M(+42.9%) |
| Jun 2019 | - | $59.10M(+9.7%) |
| Mar 2019 | - | $53.87M(+20.7%) |
| Dec 2018 | $44.62M(+801.5%) | $44.62M(+5.1%) |
| Sep 2018 | - | $42.47M(+46.9%) |
| Jun 2018 | - | $28.92M(+0.7%) |
| Mar 2018 | - | $28.71M(-72.1%) |
| Dec 2017 | $4.95M(+92.7%) | $102.83M |
| Dec 2016 | $2.57M | - |
FAQ
- What is Xeris Biopharma Holdings, Inc. annual total liabilities?
- What is the all time high annual total liabilities for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. annual total liabilities year-on-year change?
- What is Xeris Biopharma Holdings, Inc. quarterly total liabilities?
- What is the all time high quarterly total liabilities for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. quarterly total liabilities year-on-year change?
What is Xeris Biopharma Holdings, Inc. annual total liabilities?
The current annual total liabilities of XERS is $358.77M
What is the all time high annual total liabilities for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high annual total liabilities is $358.77M
What is Xeris Biopharma Holdings, Inc. annual total liabilities year-on-year change?
Over the past year, XERS annual total liabilities has changed by +$11.19M (+3.22%)
What is Xeris Biopharma Holdings, Inc. quarterly total liabilities?
The current quarterly total liabilities of XERS is $353.99M
What is the all time high quarterly total liabilities for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high quarterly total liabilities is $358.77M
What is Xeris Biopharma Holdings, Inc. quarterly total liabilities year-on-year change?
Over the past year, XERS quarterly total liabilities has changed by +$2.97M (+0.85%)